The FDA Is ‘Finished’ as Firings Sweep Health Agencies. Drug Stocks Are Falling.
The FDA as we’ve known it is finished, with most of the leaders with institutional knowledge and a deep understanding of ...
The health industry is starting to express alarm about RFK Jr.
Drug and medical device makers didn’t oppose Robert F. Kennedy Jr.’s confirmation as health secretary, but are speaking up in ...
STAT1d
Ouster of FDA’s Peter Marks alarms a biopharma industry that saw him as an ally
Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...
Drugmakers face market turmoil following FDA shakeup and Trump health overhaul
The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.
FDA tobacco official is removed from post in latest blow to health agency’s leadership
The Food and Drug Administration’s chief tobacco regulator has been forced out. Brian King's departure Tuesday comes just ...
Trump begins mass layoffs at FDA, CDC, other US health agencies
The Trump administration began mass layoffs of 10,000 staffers at U.S. health agencies on Tuesday, according to multiple ...
US FDA insider Steele replaces Marks as top vaccine official, for now
The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for Biologics Evaluation and Research (CBER), following the exit of top vaccine ...
STAT14h
Marks’ exit is not exactly helping industry sentiment
Vaccine makers were hit particularly hard yesterday, as Marks’ resignation letter alluded to disagreements with HHS Secretary ...
Fierce Pharma1d
As FDA's Peter Marks resigns, industry watchers size up vaccine, cell and gene therapy hits
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...
Makary’s FDA Has Options In Industry Fight Over Weight Loss Drugs
Americans pay far more for GLP-1 drugs than citizens in other wealthy nations. If Dr. Marty Makary, the new FDA commissioner, ...
MedTech Dive11h
Texas judge overturns FDA’s lab developed test regulation, siding with industry groups
The judge vacated the FDA’s final rule, which was strongly opposed by the laboratory industry, and remanded the matter to HHS ...
Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation ...